Dr. Victor Polshin and colleagues showed that peripheral nerve blocks reduced PACU time in a retrospective study at an academic center. @dr_rajgupta@ESchwenkMD@harvardmed https://t.co/Zx0VYr4l2d
Could intravenous ferric carboxymaltose be a therapeutic option in COPD? https://t.co/PnE4HwuZBd At 8 wks 6MWD ⬆️ by 24±28 m (FCM group) vs 10±29 m (Placebo): average treatment effect of FCM:12.6 m, 95% CI 1.6 to 23.5 m #COPD#Iron#BMJOpenRespiratoryResearch#BORR#OpenAccess